Findings support deep learning ex vivo drug screening with patient tissue as a promising tool to identify effective, individual treatments in advanced blood cancer over conventional methods Custom
/PRNewswire/ A new study from The Leukemia & Lymphoma Society (LLS), published in Blood Cancer Discovery, a journal of the American Association for Cancer.
/PRNewswire/ A new study from The Leukemia & Lymphoma Society (LLS), published in Blood Cancer Discovery, a journal of the American Association for Cancer.